Sanofi-Aventis Expands R&D Presence In China

SHANGHAI - Sanofi-Aventis recently expanded its R&D presence in China to meet the rapid growth of clinical programs and broaden its activities from drug-target identification to late-stage clinical studies

More from Archive

More from Scrip